Cloning and heterologous expression of P450Um-1, a novel bacterial P450 gene, for hydroxylation of immunosuppressive agent AS1387392

スポンサーリンク

概要

• 論文の詳細を見る
• 2010-11-25

著者

• Fujie Akihiko

  Fermentation Research Laboratories Fujisawa Pharmaceutical Co. Ltd.

• Hashimoto Michizane

  Fermentation Research Laboratories Drug Discovery Research Astellas Pharma Inc.

• Hashimoto Michizane

  Exploratory Research Laboratories Fujisawa Pharmaceutical Co. Ltd.

• Hino Motohiro

  Fermentation Research Laboratories Fujisawa Pharmaceutical Co. Ltd.

• Fujie Akihiko

  Exploratory Research Laboratories Fujisawa Pharmaceutical Co. Ltd.

• Shigematsu Nobuharu

  Exploratory Research Laboratories Fujisawa Pharmaceutical Co. Ltd.

• Hino Motohiro

  Exploratory Research Laboratories Fujisawa Pharmaceutical Co. Ltd.

• Hino Motohiro

  Fermentation Research Laboratories Drug Discovery Research Astellas Pharma Inc.

• Yamashita Midori

  Fermentation Research Laboratories Fujisawa Pharmaceutical Co. Ltd.

• Hino Motohiro

  Fermentation And Biotechnology Laboratories Astellas Pharma Inc.

• Hashimoto Michizane

  Fermentation And Biotechnology Laboratories

• Ueno Motoi

  Fermentation Research Labs Astellas Pharma Inc.

• Fujie Akihiko

  Research Planning And Administration Astellas Pharma

• Ueno Motoi

  Pharmacology Research Laboratories

• SASAMURA Satoshi

  Pharmacology Research Laboratories, Astellas Pharma Inc.

• YAMASHITA Midori

  Pharmacology Research Laboratories

• Shigematsu Nobuharu

  Exploratory Research Division Astellas Research Technologies

• Fujie Akihiko

  Research Planning & Administration

• Fujie Akihiko

  Research Management, Astellas Pharma Inc.

関連論文

• The Novel Gluconeogenesis Inhibitors FR225659 and Related Compounds that Originate from Helicomyces sp. No. 19353 : II. Biological Profiles
• Naphthalecin, a Novel Antibiotic Produced by the Anaerobic Bacterium, Sporotalea colonica sp. nov.
• FR901512, a Novel HMG-CoA Reductase Inhibitor Produced by an Agonomycetous Fungus No. 14919 : II. Biological Profiles
• FR901512, a Novel HMG-CoA Reductase Inhibitor Produced by an Agonomycetous Fungus No. 14919 : I. Taxonomy of the Producing Organism, Fermentation, Islation and Physico-chemical Properties
• FR171456, a Novel Cholesterol Synthesis Inhibitor Produced by Sporormiella minima No. 15604 : II. Biological Activities
• FR171456, a Novel Cholesterol Synthesis Inhibitor Produced by Sporormiella minima No. 15604 : I. Taxonomy, Fermentation, Isolation, Physico-chemical Properties
• The Novel Gluconeogenesis Inhibitors FR225659 and Related Compounds that Originate from Helicomyces sp. No.19353 : I. Taxonomy, Fermentation, Isolation and Physico-chemical Properties
• FR235222, a Fungal Metabolite, is a Novel Immunosuppressant that Inhibits Mammalian Histone Deacetylase (HDAC) II. Biological Activities in Animal Models
• FR252921, a Novel Immunosuppressive Agent Isolated from Pseudomonas fluorescens No.408813 III. In Vivo Activities
• FR235222, a Fungal Metabolite, is a Novel Immunosuppressant that Inhibits Mammalian Histone Deacetylase (HDAC) I. Taxonomy, Fermentation, Isolation and Biological Activities
• FR252921, a Novel Immunosuppressive Agent Isolated from Pseudomonas fluorescens No.408813 II. In Vitro Property and Mode of Action
• FR901469, a Novel Antifungal Antibiotic from an Unidentified Fungus No.11243 : II. In Vitro and In Vivo Activities
• Total Synthesis of WS9326A, a Potent Tachykinin Antagonist from Streptomyces violaceoniger
• FR227673 and FR190293, Novel Antifungal Lipopeptides from Chalara sp. No. 22210 and Tolypocladium parasiticum No. 16616
• FR207944, an Antifungal Antibiotic from Chaetomium sp. No. 217 : I. Taxonomy, Fermentation, and Biological Properties
• FR227244, a Novel Antifungal Antibiotic from Myrothecium cinctum No. 002 : II. Biological Properties and Model of Action
• FR235222, a Fungal Metabolite, is a Novel Immunosuppressant that Inhibits Mammalian Histone Deacetylase III. Structure Determination
• A New Antimitotic Substance, FR182877 : II. The Mechanism of Action
• Site-specific Structural Transformation of the Novel Antifungal Cyclic Depsipeptide FR901469 : Synthesis and Biological Activity of FR203904
• FR220897 and FR220899, Novel Antifungal Lipopeptides from Coleophoma empetri No. 14573
• FR209602 and Related Compounds, Novel Antifungal Lipopeptides from Coleophoma crateriformis No. 738 : II. In Vitro and In Vivo Antifungal Activity
• FR227244, a Novel Antifungal Antibiotic from Myrothecium cinctum No. 002 : I. Taxonomy, Fermentation, Isolation and Physico-chemical Properties
• FR901469, a Novel Antifungal Antibiotic from an Unidentified Fungus No. 11243 : III. Structure Determination
• FR901469, a Novel Antifungal Antibiotic from an Unidentified Fungus No.11243 : I. Taxonomy, Fermentation, Isolation, Physico-chemical Properties and Biological Properties
• FR209602 and Related Compounds, Novel Antifungal Lipopeptides from Coleophoma crateriformis No. 738 : I. Taxonomy, Fermentation, Isolation and Physico-chemical Properties
• FR198248, a New Anti-influenza Agent isolated from Aspergillus terreus No.13830 : I. Taxonomy, Fermentation, Isolation, Physico-chemical Properties and Biological Activities
• FR901483, a Novel Immunosuppressant Isolated from Cladobotryum sp. No. 11231 Taxonomy of the Producing Organism, Fermentation, Isolation, Physico-chemical Properties and Biological Activities
• FR207944, an Antifungal Antibiotic from Chaetomium sp. No. 217 : II. Isolation and Structure Elucidation
• Oxidative Activities of Heterologously Expressed CYP107B1 and CYP105D1 in Whole-Cell Biotransformation Using Streptomyces lividans TK24(ENZYMOLOGY, PROTEIN ENGINEERING, AND ENZYME TECHNOLOGY)
• The Novel Gluconeogenesis Inhibitor FR225654 that Originates from Phoma sp. No. 00144 : II. Biological Activities
• The Novel Gluconeogenesis Inhibitor FR225654 that Originates from Phoma sp. No. 00144 : I. Taxonomy, Fermentation, Isolation and Physico-chemical Properties
• The Novel Gluconeogenesis Inhibitors FR225659 and FR225656 from Helicomyces sp. No. 19353 : III. Structure Determination
• FR252921, a Novel Immunosuppressive Agent Isolated from Pseudomonas fluorescens No.408813 I. Taxonomy, Ferimentation, Isolation, Physico-chemical Properties and Biological Activities of FR252921, FR252922 and FR256523
• FR191512 , a Novel Anti-influenza Agent Isolated from a Fungus Strain No.17415 : II. Biological Properties
• FR191512 , a Novel Anti-influenza Agent Isolated from a Fungus Strain No.17415 : I. Taxonomy, Fermentation, Isolation, Physico-chemical Properties and Structure Elucidation
• FR225659-binding Proteins : Identification as Serine/Threonine Protein Phosphatase PP1 and PP2A Using High-performance Affinity Beads
• A Comparative Study of Malaysian and Japanese Actinomycetes Using a Simple Identification Method Based on Partial 16S rDNA Sequence
• A New Antimitotic Substance, FR182877 : I. Taxonomy, Fermentation, Isolation, Physico-chemical Properties and Biological Activities
• WF14865A and B, New Cathepsins B and L Inhibitors Produced by Aphanoascus fulvescens I. Taxonomy, Production, Purification and Biological Properties
• WF14861, a New Cathepsins B and L Inhibitor Produced by Colletotrichum sp. I. Taxonomy, Production Purification and Structure Elucidation
• WF14861, a New Cathepsins B and L Inhibitor Produced by Collectotrichum sp. II. Biological Properties
• Strain selection and scale-up fermentation for FR901379 acylase production by Streptomyces sp. no. 6907(METHOD)
• Cloning and expression of the FR901379 acylase gene from Streptomyces sd. no. 6907
• Anti-herpes virus activity of polyether antibiotic CP-44161 in vivo
• Discovery of anti-varicella zoster virus activity of polyether antibiotic CP-44161
• Screening and characterization of microorganisms with FR901379 acylase activity
• AS1387392, a novel immunosuppressive cyclic tetrapeptide compound with inhibitory activity against mammalian histone deacetylase
• Cloning and heterologous expression of P450Um-1, a novel bacterial P450 gene, for hydroxylation of immunosuppressive agent AS1387392
• Bioconversion of AS1387392 : bioconversion studies involving Amycolatopsis azurea JCM 3275
• Bioconversion of AS1387392 : screening and characterization of actinomycetes that convert AS1387392 to AS1429716
• Enhanced oxidative activities of cytochrome P450Rhf from Rhodococcus sp. expressed using the hyper-inducible expression system(GENETICS, MOLECULAR BIOLOGY, AND GENE ENGINEERING)

もっと見る 閉じる

スポンサーリンク